SCHIZOPHRENIFORM DISORDERS
Clinical trials for SCHIZOPHRENIFORM DISORDERS explained in plain language.
Never miss a new study
Get alerted when new SCHIZOPHRENIFORM DISORDERS trials appear
Sign up with your email to follow new studies for SCHIZOPHRENIFORM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
ER agitation study halted before it began
Symptom relief TerminatedThis study aimed to see if a sublingual film of dexmedetomidine (BXCL501) could quickly reduce agitation in adults with bipolar disorder or schizophrenia visiting the emergency department. It was a single-arm pilot study, but it was withdrawn before enrolling any participants. No…
Matched conditions: SCHIZOPHRENIFORM DISORDERS
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated May 17, 2026 07:36 UTC
-
Writing your way to wellness: new study tests creative writing groups for mental health
Symptom relief OngoingThis study tests a 15-session creative writing program called REWRITALIZE for people with serious mental illnesses like schizophrenia, bipolar disorder, or severe depression. The program is led by a professional author and a mental health worker, and focuses on writing, sharing, …
Matched conditions: SCHIZOPHRENIFORM DISORDERS
Phase: NA • Sponsor: Amager Hospital • Aim: Symptom relief
Last updated May 12, 2026 13:41 UTC
-
New therapy aims to curb violence in young psychosis patients
Symptom relief OngoingThis study tests a behavioral therapy designed to reduce violent behavior in young adults (ages 16-30) who have early psychosis, including schizophrenia. The therapy is offered through early psychosis clinics. The main goal is to see if the therapy is acceptable and practical for…
Matched conditions: SCHIZOPHRENIFORM DISORDERS
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC